Trial Outcomes & Findings for Oxytocin Add on Study for Stable Schizophrenic Patients (NCT NCT00506909)
NCT ID: NCT00506909
Last Updated: 2019-09-25
Results Overview
TERMINATED
NA
21 participants
performed at each visit (weekly)
2019-09-25
Participant Flow
The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed.
Participant milestones
| Measure |
All Participants
|
|---|---|
|
Overall Study
STARTED
|
0
|
|
Overall Study
COMPLETED
|
0
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Oxytocin Add on Study for Stable Schizophrenic Patients
Baseline characteristics by cohort
Baseline data not reported
PRIMARY outcome
Timeframe: performed at each visit (weekly)Population: The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: performed at each visit (weekly)Population: The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: performed at each visit (weekly)Population: The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Performed at Visits 2-8 (weekly)Population: The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: performed at each visit (weekly)Population: The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: performed at each visit (weekly)Population: The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Visit 1 onlyPopulation: The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Visits 1, 4, and 8 (every 4 weeks)Population: The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Visits 1, 4, 5 and 8 (every 4 weeks)Population: The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Visits 1, 4, and 8 (every 4 weeks)Population: The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Visits 1 and 5 (first visit and 5 weeks later)Population: The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Visits 1-8 (weekly)Population: The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Visits 1-8 (weekly)Population: The PI has left the institution and this study was terminated due to loss of funding. The data was not analyzed.
Outcome measures
Outcome data not reported
Adverse Events
All Participants
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place